Health
Regeneron suspends Covid-19 antibody trial among sickest patients – UrduPoint News
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients who require high-flow…
Washington, (UrduPoint / Pakistan Point News – 30th Oct, 2020 ) :US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
The move follows a recommendation from an independent data monitoring committee (IDMC) which assesses the results and advises when it’s necessary to halt a study.
“Based on a potential safety signal and an unfavorable risk/benefit profile…
-
Noosa News24 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
General17 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
General22 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse
-
Noosa News24 hours ago‘The Book of Mormon’ Returns to Melbourne and Brisbane in 2026